ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL

BAUDETTE, Minn., Dec. 18, 2019 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Bretylium Tosylate Injection USP, 50 mg/mL. Bretylium Tosylate is a class III antiarrhyth... Biopharmaceuticals, Cardiology, Product Launch ANI Pharmaceuticals, Bretylium, ventricular arrhythmia, tachycardia

Source: HSMN NewsFeed - December 18, 2019 Category: Pharmaceuticals Source Type: news